ARCHIVES

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

This article is from The Cancer Letter archive.

Vol. 09 No. 05 | February 4, 1983

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

In Brief: Cancer Control Month: Reagan Advises Americans To Stop Tobacco Use; Eat More Fiber, Less Fat

April 18, 1986

Impath Buys Clinical Studies Support Services Network.

September 28, 2001

DOD funds $4.2 million gynecologic oncology research program at four institutions.

July 2, 2004

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994

Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy

June 27, 2014